Sponsor or institution
Clinical trials and research at Second Affiliated Hospital of Guangzhou Medical University
As of November 12, 2026, Find a Trial lists 39 clinical trials run by Second Affiliated Hospital of Guangzhou Medical University that are recruiting, in China. By phase: Phase 2 (11), Phase 1 (11), Phase 3 (4), Phase 1/2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 39Clinical trials
- 1Country
Newest trials
All recruiting trials (39)
-
RC001 in Children with Dravet Syndrome: A Safe, Investigational Test in 2-18 Year Olds
This study tests RC001 given into the spine to see if it is safe and tolerable in kids with Dravet syndrome aged 2 to 18 who have SCN1A mutations.
-
Comparing three-drug blood sugar regimens for adults newly diagnosed with type 2 diabetes
This test compares semaglutide versus sitagliptin, each given with metformin and empagliflozin, to see which better controls blood sugar and promotes remission in adults newly diagnosed with type 2 diabetes and HbA1c ≥ 9%.
-
Combining Lenvatinib with SIRT for Advanced Liver Cancer
This study is testing whether combining a cancer drug called lenvatinib with a type of radiation therapy can help people with advanced liver cancer that hasn't improved with other treatments.
-
Combination treatment for large liver cancer with portal vein involvement
This study is testing a new combination treatment for people with large liver cancer that has spread to the portal vein to see if it works better than the standard treatment.
-
Yttrium-90 treatment for large liver cancer
This study is testing whether a special radiation treatment using yttrium-90 can help people with large liver cancer that can’t be surgically removed feel better and live longer.
-
Neoadjuvant double immunotherapy for lung cancer treatment
This study is testing a new way to treat early-stage lung cancer by using a combination of two immune therapies injected directly into the tumor to see if it helps patients feel better and live longer.
-
Neoadjuvant immunotherapy for liver cancer
This study is testing a new way to deliver immunotherapy directly into liver tumors to see if it helps patients with liver cancer feel better and have better treatment results before surgery.
-
Combining lenvatinib with TACE and HAIC for large liver cancer with portal vein thrombosis
This study is testing a new combination treatment for people with large liver cancer and blood clots in the portal vein to see if it works better than just one of the treatments alone.
-
Combination therapy for inoperable lung cancer using intra-tumor injections
This study is testing a new way to treat inoperable lung cancer by combining special injections with chemotherapy to see if it helps patients live longer and feel better.
-
Combination therapy using checkpoint inhibitors for liver cancer treatment
This study is testing a new way to treat liver cancer by combining special immune drugs with chemotherapy to see if it helps patients feel better and live longer.
-
Software-guided immunotherapy for advanced solid tumors
This study is testing a new AI software that suggests a mix of immunotherapy drugs for people with advanced solid tumors, like lung and liver cancers, to see if it helps them respond better to treatment while reducing side effects.
-
Vaccination using immune cells to treat solid tumors
This study is testing a new vaccine made from immune cells to see if it can help people with advanced solid tumors fight their cancer safely.
-
Combining DEB-TACE with HAIC for large liver cancer
This study is testing if combining two types of chemotherapy treatments can help people with large liver cancer live longer and feel better compared to just one treatment.
-
Combination treatment for advanced liver cancer
This study is testing a new combination of treatments for advanced liver cancer to see if it helps patients live longer and feel better.
-
CAR-γδT cell therapy targeting GPC3 and Mesothelin for cancer treatment
This study is testing a new cancer treatment that uses modified immune cells to target specific proteins in patients with advanced solid tumors.
-
mRNA vaccine for treating solid tumors
This study is testing a new mRNA vaccine for people with advanced solid tumors to see if it can safely help their bodies fight cancer.
-
Vaccine to treat solid tumors using neoantigens
This study is testing a personalized vaccine made from cancer markers to see if it can help people with advanced solid tumors feel better and improve their treatment outcomes.
-
Selective internal radiation therapy for liver cancer
This study is testing if a special type of radiation therapy can help patients with liver cancer become healthy enough for surgery.
-
Comparing two treatment combinations for advanced liver cancer
This study is testing two different treatment combinations for advanced liver cancer to see which one helps patients live longer after their first round of a specific procedure.
-
Controlling heart rate with Ivabradine in sepsis patients
This study is testing if adding Ivabradine to standard treatment can help lower heart rates in sepsis patients who have a fast heartbeat and see if it improves their overall health and survival.
-
CAR-T cell therapy targeting mesothelin for cancer treatment
This study is testing a new CAR-T cell therapy that targets a specific protein in advanced cancers, like pancreatic cancer, to see if it can help patients feel better and fight their disease.
-
Combining lenvatinib with iodine-125 seed brachytherapy for treating liver cancer
This study is testing if combining a medication called lenvatinib with a special type of radiation therapy can help people with liver cancer that hasn't improved with other treatments live longer and feel better.
-
CAR-NK cell therapy for advanced solid tumors
This study is testing a new treatment using specially modified immune cells to see if they can help people with advanced solid tumors like ovarian and testis cancers.
-
CAR-T therapy targeting EGFR and B7H3 for advanced lung and breast cancer
This study is testing a new CAR-T therapy for people with advanced lung cancer and triple-negative breast cancer to see if it helps them by targeting specific proteins in their tumors.
-
Combination therapy using checkpoint inhibitors for advanced solid tumors
This study is testing a new combination treatment using special antibodies for people with advanced solid tumors like lung and liver cancer to see if it can be safer and more effective than current options.
-
Treatment for advanced non-small cell lung cancer using modified CAR-T cells
This study is testing a new type of CAR-T cell treatment for people with advanced non-small cell lung cancer to see if it is safe and works better than standard therapies.
-
Injecting CpG-ODN to enhance immune response against advanced solid tumors
This study is testing whether injecting a special substance into tumors can help the immune system fight advanced solid tumors better, either on its own or with another treatment that targets specific cancer cells.
-
Engineered TILs and CAR-TILs for treating advanced solid tumors
This study is testing a new way to treat advanced solid tumors by using specially modified immune cells from patients to see if they can better fight the cancer.
-
Combination treatment for advanced solid tumors using Trametinib, Everolimus, and Lenvatinib
This study is testing a new combination of three drugs to see if it can help people with advanced solid tumors, like liver cancer, feel better and improve their condition.
-
Injection of drug-eluting microspheres into tumors
This study tests if injecting tiny drug-filled beads directly into advanced tumors can safely help people with cancer feel better and improve their treatment outcomes.
-
Infusion methods for immunotherapy in head and neck cancers
This study is testing whether delivering immunotherapy directly into head and neck tumors or arteries can help advanced cancer patients live longer and feel better compared to the usual IV method.
-
Infusion of immune inhibitors for liver cancer treatment
This study is testing whether delivering immune inhibitors directly into the liver can help people with advanced liver cancer live longer and feel better compared to traditional methods.
-
New immunotherapy using T-like NK cells for cancer without MHC-I
This study is testing a new cancer treatment that uses modified immune cells to help patients with advanced cancers that don't have certain markers for existing therapies.
-
TCR-T cell immunotherapy for lung cancer and solid tumors
This study is testing a new immunotherapy that uses specially modified T cells to see if it can help people with advanced lung cancer and other solid tumors.
-
Combining Pembrolizumab with Microwave Ablation for Advanced Lung Cancer
This study is testing if combining an immunotherapy drug called Pembrolizumab with a heat treatment can help people with advanced lung cancer who haven't responded to other treatments feel better and live longer.
-
Infusion of checkpoint inhibitors and chemotherapy for advanced solid tumors
This study is testing if giving a mix of immune therapy and chemotherapy directly to tumors helps people with advanced cancers feel better compared to the usual way of giving these treatments.
-
Immunotherapy using GPC3-targeted CAR-T cells for liver cancer
This study is testing a new treatment using specially modified immune cells to see if they can help people with advanced liver cancer that has a specific protein called GPC3.
-
CAR-T cell therapy targeting multiple cancer markers
This study is testing a new CAR-T cell therapy that aims to help patients with advanced lung cancer and other cancers by using their own modified immune cells to target specific cancer markers.
-
Using iCAGES to guide cancer treatment for better outcomes
This study is testing if a new tool called iCAGES can help doctors choose better treatments for people with advanced cancers, like lung cancer, to see if it improves their survival and quality of life compared to standard care.
Quick answers
How many clinical trials run by Second Affiliated Hospital of Guangzhou Medical University are recruiting right now?
39, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 11, Phase 1: 11, Phase 3: 4, Phase 1/2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.